Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chung-Feng Huang

Showing results (21-30 of 286) with videos related to

Pageof 29
Sort By:
The Kaohsiung Journal of Medical Sciences|December 31, 2024
Safety of transarterial chemoembolization on renal function in combined hepatocellular carcinoma and chronic kidney disease patientsZu-Yau Lin, Ming-Lun Yeh, Po-Cheng Liang, et al.
Diagnostics (Basel, Switzerland)|June 19, 2024
Post-Treatment Occurrence of Serum Cryoglobulinemia in Chronic Hepatitis C PatientsGantogtokh Dashjamts, Amin-Erdene Ganzorig, Yumchinsuren Tsedendorj, et al.
Pathogens (Basel, Switzerland)|October 23, 2021
The Prevalence and Serological Association of Hepatitis D Virus Genotypes in TaiwanKeva Joseph, Ciniso Sylvester Shabangu, Tyng-Yuan Jang, et al.
BMJ Open Gastroenterology|December 16, 2020
Less liver fibrosis marker increment in overweight chronic hepatitis B patients observed by age-adjusted Fibrosis-4 IndexTa-Wei Liu, Chung-Feng Huang, Ming-Lun Yeh, et al.
Cancers|October 28, 2023
Dose Consideration of Lenvatinib's Anti-Cancer Effect on Hepatocellular Carcinoma and the Potential Benefit of Combined Colchicine TherapyZu-Yau Lin, Ming-Lun Yeh, Po-Cheng Liang, et al.
The Kaohsiung Journal of Medical Sciences|April 11, 2022
The compound annual growth rate of the fibrosis-4 index in chronic hepatitis B patientsTa-Wei Liu, Chung-Feng Huang, Pei-Chien Tsai, et al.
Journal of Gastroenterology and Hepatology|October 13, 2017
Interference of hepatitis B virus dual infection in platelet count recovery in chronic hepatitis C patients with curative antiviral therapyChung-Feng Huang, Ming-Lun Yeh, Ching-I Huang, et al.
The Kaohsiung Journal of Medical Sciences|January 21, 2015
Clinical performance of a new hepatitis B surface antigen quantitative assay with automatic dilutionTa-Wei Liu, Ming-Lun Yeh, Chung-Feng Huang, et al.
The Kaohsiung Journal of Medical Sciences|September 27, 2025
Phase IIb Trial for the Palliative Treatment of Patients With Primary Hepatic Malignancy Unable to Receive Curative Treatment: Efficacy of ColchicineZu-Yau Lin, Ming-Lun Yeh, Po-Cheng Liang, et al.
Journal of Gastroenterology and Hepatology|October 20, 2015
Long-term efficacy of Peg-Interferon/Ribavirin with and without Lamivudine therapy for HBeAg-positive hepatitis B and C dual infectionMing-Lun Yeh, Ming-Yen Hsieh, Ching-I Huang, et al.
Pageof 29

Showing results (21-30 of 286) with videos related to

Sort By:
Pageof 29
The Kaohsiung Journal of Medical Sciences|December 31, 2024
Safety of transarterial chemoembolization on renal function in combined hepatocellular carcinoma and chronic kidney disease patientsZu-Yau Lin, Ming-Lun Yeh, Po-Cheng Liang, et al.
Diagnostics (Basel, Switzerland)|June 19, 2024
Post-Treatment Occurrence of Serum Cryoglobulinemia in Chronic Hepatitis C PatientsGantogtokh Dashjamts, Amin-Erdene Ganzorig, Yumchinsuren Tsedendorj, et al.
Pathogens (Basel, Switzerland)|October 23, 2021
The Prevalence and Serological Association of Hepatitis D Virus Genotypes in TaiwanKeva Joseph, Ciniso Sylvester Shabangu, Tyng-Yuan Jang, et al.
BMJ Open Gastroenterology|December 16, 2020
Less liver fibrosis marker increment in overweight chronic hepatitis B patients observed by age-adjusted Fibrosis-4 IndexTa-Wei Liu, Chung-Feng Huang, Ming-Lun Yeh, et al.
Cancers|October 28, 2023
Dose Consideration of Lenvatinib's Anti-Cancer Effect on Hepatocellular Carcinoma and the Potential Benefit of Combined Colchicine TherapyZu-Yau Lin, Ming-Lun Yeh, Po-Cheng Liang, et al.
The Kaohsiung Journal of Medical Sciences|April 11, 2022
The compound annual growth rate of the fibrosis-4 index in chronic hepatitis B patientsTa-Wei Liu, Chung-Feng Huang, Pei-Chien Tsai, et al.
Journal of Gastroenterology and Hepatology|October 13, 2017
Interference of hepatitis B virus dual infection in platelet count recovery in chronic hepatitis C patients with curative antiviral therapyChung-Feng Huang, Ming-Lun Yeh, Ching-I Huang, et al.
The Kaohsiung Journal of Medical Sciences|January 21, 2015
Clinical performance of a new hepatitis B surface antigen quantitative assay with automatic dilutionTa-Wei Liu, Ming-Lun Yeh, Chung-Feng Huang, et al.
The Kaohsiung Journal of Medical Sciences|September 27, 2025
Phase IIb Trial for the Palliative Treatment of Patients With Primary Hepatic Malignancy Unable to Receive Curative Treatment: Efficacy of ColchicineZu-Yau Lin, Ming-Lun Yeh, Po-Cheng Liang, et al.
Journal of Gastroenterology and Hepatology|October 20, 2015
Long-term efficacy of Peg-Interferon/Ribavirin with and without Lamivudine therapy for HBeAg-positive hepatitis B and C dual infectionMing-Lun Yeh, Ming-Yen Hsieh, Ching-I Huang, et al.
Pageof 29